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Spinal cord injury (SCI) affects 6 million people worldwide with no available treatment.
Despite research advances, the inherent poor regeneration potential of the central
nervous system remains a major hurdle. Small RNAs (sRNAs) 19–33 nucleotides in
length are a set of non-coding RNA molecules that regulate gene expression and
have emerged as key players in regulating cellular events occurring after SCI. Here we
profiled a class of sRNA known as microRNAs (miRNAs) following SCI in the cortex
where the cell bodies of corticospinal motor neurons are located. We identified miR-
7b-3p as a candidate target given its significant upregulation after SCI in vivo and we
screened by miRWalk PTM the genes predicted to be targets of miR-7b-3p (among
which we identified Wipf2, a gene regulating neurite extension). Moreover, 16 genes,
involved in neural regeneration and potential miR-7b-3p targets, were found to be
downregulated in the cortex following SCI. We also analysed miR-7b-3p function during
cortical neuron development in vitro: we observed that the overexpression of miR-7b-3p
was important (1) to maintain neurons in a more immature and, likely, plastic neuronal
developmental phase and (2) to contrast the apoptotic pathway; however, in normal
conditions it did not affect the Wipf2 expression. On the contrary, the overexpression
of miR-7b-3p upon in vitro oxidative stress condition (mimicking the SCI environment)
significantly reduced the expression level of Wipf2, as observed in vivo, confirming it
as a direct miR-7b-3p target. Overall, these data suggest a dual role of miR-7b-3p:
(i) the induction of a more plastic neuronal condition/phase, possibly at the expense
of the axon growth, (ii) the neuroprotective role exerted through the inhibition of the
apoptotic cascade. Increasing the miR-7b-3p levels in case of SCI could reactivate in
adult neurons silenced developmental programmes, supporting at the same time the
survival of the axotomised neurons.
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INTRODUCTION
Around 6 million people worldwide live with a significant
disability caused by traumatic spinal cord injury (SCI), which
is associated with devastating social impact plus huge economic
cost (Singh et al., 2014). Immediately after a SCI event, timely
surgical intervention is critical to stabilise the lesion. The glial
scar that forms at the site of the lesion produced by reactive
astrocytes delimiting the area becomes a temporal obstacle for
axon regeneration. When therapeutic strategies are applied at
later stages, they are generally ineffective. The acute/intermediate
phase when the formation of glial scar is not yet complete is
an appropriate window to efficiently promote the regeneration
process (Tran et al., 2018). Motor disabilities that follow SCI
trauma are essentially due to axotomised corticospinal fibres
[corticospinal motor neurons (CSMNs) whose cell body is
located in the layer V of the cortex] that are unable to
re-establish functional connections. Despite CSMN attempts
to regenerate, their efforts fail because of a non-permissive
regrowth environment, neurotrophic factor deprivation and
inhibitory myelin-associated molecules (Brown and Martinez,
2019; Xu A.K. et al., 2019). No successful treatment is available
for SCI patients although several therapeutic interventions
such as cell engraftment, 3D scaffolds and gene therapy are
currently under investigation. These interventions aim to reduce
glial scar formation and to promote neuronal regeneration
(Assinck et al., 2017; Boido et al., 2019; Cofano et al., 2019;
Zhang et al., 2019).
In the last two decades, a class of small RNA (sRNA) gene
regulatory molecules termed microRNAs (miRNAs) emerged
as promising targets in SCI. miRNAs are transcripts ∼22
nucleotides in length that bind to the 3′UTR of target messenger
RNA (mRNA) leading to translational inhibition (Green et al.,
2016; Pinchi et al., 2019). miRNAs are abundantly expressed in
the central nervous system (CNS) with specific temporal and
spatial patterns contributing to highly accurate control of gene
expression both in physiological and pathological conditions
(Cao et al., 2016). As a consequence of SCI, miRNAs purportedly
undergo a sustained change in their expression profile leading
to downstream gene regulatory effects. Potential of miRNAs
in the context of SCI lies in the double possibility to exploit
them as diagnostic markers and to manipulate their expression
through a mimic/antagomir strategy (Almurshidi et al., 2019).
As key mediators of several neuronal processes both in the brain
and spinal cord, miRNAs are commonly classified into specific
functional groups depending on the role they are exerting. Entire
miRNA families or clusters have been attributed to selectively
regulate axon guidance and outgrowth pathways (e.g., miR-430
family and miR-17-92 cluster) at developmental levels as well
as to modulate the inflammation, proliferation, neuroprotection,
apoptosis, and regeneration processes after SCI (Nieto-Diaz
et al., 2014; Ning et al., 2014). Immediately after injury, there
is a significant increase in the expression of regeneration and
neuroprotection associated genes, a phenomenon controlled
by the early activation of specific transcriptional factors that
are regulated by several miRNAs. For example, miR-21, miR-
29, and miR-199 (acting on the PTEN/mTOR pathway) have
been already described to influence axonal regrowth after SCI
(Ning et al., 2014; Sun et al., 2018). Strategies that specifically
target one single miRNA or a specific set of miRNAs may
promote functional recovery after SCI (Ghibaudi et al., 2017; Shi
et al., 2017). Although the list of miRNAs functionally involved
in axonal regrowth/plasticity is extensive in the literature,
there is a lack of experimental evidence investigating miRNA
networks acting on these processes in vivo. The majority of
non-coding RNAs investigated in SCI studies are generally
focused only on the spinal cord, disregarding the cerebral
cortex where CSMNs reside. These cells undergo a structural
remodelling within the cortex that can have a significant impact
on the molecular mechanisms driving the processes after a SCI
lesion manifests.
Global identification of sRNAs via library construction and
next generation sequencing is biassed for sequences that can
readily anneal to adapters with a fixed sequence. miRNAs
that have a lower annealing efficiency are less likely to be
ligated to adapters and less probable to be sequenced. To
enhance characterisation of the miRNA population, we used
high definition (HD) adapters that contain four degenerate
assigned nucleotides at the ligating ends of HiSeq 2500 adapters.
We profiled miRNAs at the cortical level in the acute phase
following a traumatic SCI in order to characterise those
involved in the regeneration and neuroprotection processes.
We investigated the sensorimotor cortex of both young and
adult mice when neuronal networks are still refining [Postnatal
15 (P-15)] and when the CNS is considered mature and less
plastic (postnatal day 90 or P-90) so to establish an age-
related effect. We defined two time points 12 h and 3 days
after SCI in order to identify those miRNAs acting in the
primary and secondary phase when the therapeutic approaches
are more effective. We observed an upregulation of miR-7b-
3p in the cortex of SCI mice. To better understand the role
of this miRNA, we carried out a number of ex vivo and
in vitro experiments, finally suggesting that the regulation of




C57BL/6J male mice were purchased from Envigo (Udine,
Italy). Animals were maintained under standard conditions with
free access to food and water. All experimental procedures
on live animals were performed according to the European
Activities Communities Council Directive of 86/609/EEC 1986
and University of Turin institutional guidelines on animal welfare
(authorisation number 17/2010-B). P-15 and P-90 mice were
divided into two groups: SCI mice (n = 55) and sham controls
(n = 61). Mice were anaesthetised and injured as previously
described (Boido et al., 2009). Briefly, the cervical spine was
exposed and spinal muscles were displaced laterally. The lesion
was performed by exposing the entire spinal cord and using a
27-gauge needle, transected at C6 level. In the SHAM group, the
spinal cord was exposed without any damage.
Frontiers in Molecular Biosciences | www.frontiersin.org 2 March 2021 | Volume 8 | Article 618869
fmolb-08-618869 March 25, 2021 Time: 18:33 # 3
Ghibaudi et al. miR-7b-3p in Spinal Cord Injury
Histological Analysis
A set of animals (P15 n = 15, P90 n = 14) was employed for
the histological analysis of the sensorimotor cortex in order to
better characterise the SCI model. Either 12 h or 3 days after
injury both P-15 and P-90 mice were anaesthetised with 3%
isoflurane vaporised in O2/N2O 50:50 and transcardially perfused
with 0.1 M PBS, pH 7.4 followed by 4% PFA in PBS. The brain
and spinal cord (C6 level) were dissected and post-fixed for 2 h
at 4◦C in the same fixative solution. Samples were transferred
overnight into 30% 0.1M PBS at 4◦C then embedded in cryostat
medium (Killik, Bio-Optica, Milan, Italy), frozen at −70◦C in
2-methylbutane and cut on the cryostat (Microm HM 550) in
coronal and transverse 50 µm thick sections for brain and spinal
cord, respectively. Sections were collected into 1× PBS prior to
immunofluorescence reactions and Fluoro-Jade C (FJC; Histo-
Chem Inc., Jefferson, AR, United States) staining.
Immunofluorescence
For evaluating astrogliosis and microglia activation, sections were
immunolabelled with GFAP and IBA1, respectively. Briefly, after
30 min in PBS-triton 2% and 1 h in blocking solution (0.2%
Triton X-100 and 10% normal donkey serum in PBS pH 7.4)
(NDS; Sigma-Aldrich, Milan, Italy), sections were incubated with
primary antibodies (IBA1, Wako Laboratories Chemicals, 019-
09741, Japan, 1:500; GFAP, Dako Cytomation, Z0334, Denmark,
1:500) in the same solution at 4◦C overnight. Then the sections
were washed in 1× PBS and incubated with the secondary
antibody (Jackson Immuno Research Laboratories; 1:200 donkey
anti-rabbit cyanine 3-coniugated). Images of the sensorimotor
cortex were taken with Nikon DS-5Mc digital camera on a Nikon
Eclipse 80i epifluorescence microscope. Photomicrographs at
40× magnification were corrected for contrast and brightness
enhancement with ImageJ.
Fluoro-Jade C Staining
To stain degenerating neurons, sections were treated for
FJC staining (Histo-Chem Inc., Jefferson, AR, United States),
following supplier’s instructions. Brain and spinal cord sections
were mounted on 2% gelatin coated slides and dried overnight
at RT. The following day, sections were immersed in a solution
of 1% sodium hydroxide in 80% ethanol for 5 min. Then they
were rinsed for 2min in 70% ethanol, 2 min in distilled water and
then incubated in 0.06% potassium permanganate solution in 1×
PBS for 10 min. Then slides were rinsed for 2 min in distilled
water and transferred for 20 min to a 0.0004% solution of FJC
dissolved in 0.1% acetic acid. The sections were rinsed in distilled
water three times for 1 min before drying at 37◦C for ∼30 min.
Dry slides were cleared in xylene for 4 min and covered with an
anhydrous mounting medium. Pictures of sensorimotor cortex
were taken on a Nikon DS-5Mc digital camera on a Nikon Eclipse
80i epifluorescence microscope.
RNA Extraction From Sensorimotor
Cortex Samples
The whole sensorimotor cortex was isolated in order to perform
next generation sequencing (n = 3). Twelve hours/three days after
injury, SHAM controls (P-15 12 h and 3 days, P-90 12 h and
3 days) and SCI mice (P-15 12 h and 3 days, P-90 12 h and 3 days)
in triplicate experiments were sacrificed by cervical dislocation
and brains were removed. We isolated the layer V of the
sensorimotor cortices from 1 mm thick coronal sections obtained
using a brain matrix, excluding as much as possible upper and
lower layers and the subcortical white matter. The samples were
individually collected and stored at −80◦C. We extracted RNA
as previously described (Valsecchi et al., 2015) using the mirVana
extraction kit following supplier’s instruction (Life Technologies,
Milan, Italy). The quality and quantity of RNA samples was
checked by Nanodrop and the samples were stored at −80◦C
until sRNA library preparation. Only samples with a 260/280 and
260/230 ratio around 2.1 and 1.8, respectively were used.
Small RNA Library Preparation and Next
Generation Sequencing
Small RNA libraries were generated using HD adapters (Sorefan
et al., 2012; Xu et al., 2015). HD adapters contain four degenerate
nucleotides on the ligating ends of 5′ and 3′ Illumina adapters.
HD adapters represent a pool of sequences rather than one
fixed sequence, which increases the annealing efficiency between
sRNAs and adapters. Increased annealing efficiency leads to a
greater sRNA complexity in the libraries that are sequenced.
Sequencing was performed on a HiSeq 2500 (Illumina).
Bioinformatics
Raw FASTQ files were converted to FASTA format. Reads
containing unassigned nucleotides were excluded. The 3′ adapter
was trimmed by using perfect sequence similarity to the
first 8 nt of the 3′ HiSeq 2500 adapter (TGGAATTC). The
HD signatures (four assigned degenerate nucleotides at the
ligating ends) of the reads were also trimmed. sRNAs were
mapped full length with no mismatches to the mouse genome
(GRCm38.p6) and then to latest set of mouse miRNA [miRBase
(v22)] (Kozomara and Griffiths-Jones, 2014) using PatMaN (62).
Normalisation and differential expression analysis was performed
using DESeq2 (v1.2.10) (Love et al., 2014). Independent filtering
was used to remove low-expressing miRNA (<5) in normalised
counts. miRNAs were considered differentially expressed if they
had a p-value < 0.05, <5% false discovery rate according
to the Benjamini–Hochberg procedure and greater than log2
fold change >1.
Quantitative PCR
miR-7b-3p, the miRNA with the highest sequencing score
across three different groups, was selected for validation by
quantitative PCR (qPCR). Total RNA was obtained from three
SCI and three SHAM controls (sequencing samples) plus five
SCI and five SHAM from the P-15 group. We also obtained
RNA from three SCI and three SHAM controls (sequencing
samples) plus two SCI and two SHAM controls for the P-90
group. We used the high capacity cDNA reverse transcription
kit (Life Technologies) following supplier’s instructions. qPCR
was performed with SYBR green core reagent kit and TaqMan
assays (Life Technologies) on a Step-One 2000 PCR system.
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miRNA expression was analysed using RNAU6 as a housekeeping
gene and t-test as statistic method. Samples were amplified
simultaneously in triplicate in one assay run.
Functional Analysis of miR-7b-3p Targets
Functional analysis of miR-7b-3p targets was performed
following two different strategies. Based on the sequence
homology of the seed region between miR-7a-2-3p (5′-
CAACAAGUCCCAGUCUGCCACA-3′) and miR-7b-3p (5′-
CAACAAGUCACAGCCAGCCUCA-3′) we selected a list of
seven target genes already validated for miR-7a-2-3p by
MiRWalk: Zdhhc9, Wipf2, Cplx1, Basp1, Pfn2, Prkcb, and Snca.
These genes are known to be involved in neuronal differentiation.
We screened using the miRWalk PTM the genes predicted to
be targets of miR-7b-3p, selecting those genes recognised by
six different databases. DAVID 6.7 was employed to obtain
the enriched annotation terms of the listed genes. We selected
66 genes among the most interesting KEGG pathways (e.g.,
axon guidance, negative regulation of anoikis, regulation of
actin cytoskeleton, and PI3K-Akt signalling pathway) with
p-values ≤ 0.05.
Analysis of miR-7b-3p Targets
The putative selected target genes of miR-7b-3p were validated
by qPCR in the experimental groups that showed the highest
miRNA level expression. The same total RNA extracted for
miRNA validation was employed to check the expression of the
seven target genes in P-15 3 days and P-90 3 days groups, the
selected 66 genes in P-15 3 days and P-90 12 h groups. cDNA was
synthesised using the high capacity cDNA reverse transcription
kit following supplier’s instructions (Qiagen/Life Technologies).
Two different qPCRs were performed: single analysis by SYBR
green core reagent kit (Life Technologies, for the seven target
genes) or custom plates by SYBR green technology (Bio-Rad
for 66 selected genes) in a Step-One 2000 PCR system. Gene
expression was analysed using RS18 as a housekeeping gene.
Samples were amplified simultaneously in triplicate in one assay
run for the seven target list and pulled together (five SHAM
controls vs five SCI; t-test as statistic tool) for the analysis of the
66 selected genes.
Primary Cortical Neuron Cell Culture
In order to study miRNAs of interest in vitro, we isolated
and cultured murine cortical neurons as previously described
(Chiotto et al., 2019). Cells were obtained from murine C57BL/6J
brain (n = 6 different embryos each dissection) at embryonic
day 14.5 (E14.5). Cortices were dissected under the microscope
and collected in 1× HBSS supplemented with 0.7% of HEPES
and 1% of PS (Invitrogen-Gibco). Cells were enzymatically
dissociated by trypsin-EDTA 0.05% (15 min at 37◦C) and washed
in the same HBSS dissection solution. We then added DNAse
(1000U, Promega, Milan, Italy) to the dissection solution prior
to mechanical dissociation by glass Pasteur pipette. Neurons
were counted on a Burker chamber and plated at a density of
32,500 cells/cm2 on Poly-L-Lysine coated coverslips (0.1 mg/ml
poly-L-lysine) in 1× MEM medium supplemented with 20%
glucose, 1% of L-glutamine and 10% of horse serum (Invitrogen-
Gibco) and incubated at 37◦C, 5% CO2 and 95% humidity. After
4 h 1× MEM was replaced with Neurobasal supplemented with
2% of B27 and 1% of L-glutamine (Invitrogen-Gibco). Coverslips
with paraffin dots were placed inverted on the cells to create a
suitable environment for neuron differentiation. Neurons were
cultured for 1–18 days.
Neuro2a Cell Culture and Damage
Neuro2a (N2a) cells were grown in DMEM high glucose
containing 5% FBS, 1% of PS and 1% of L-glutamine (Invitrogen-
Gibco). In order to promote neurite extension, FBS concentration
was decreased from 5 to 1% for 72 h before inducing the
stress (Fukui et al., 2011). Cells were plated at a density of
32,000 cells/cm2 and were treated with 0.5 µM of hydrogen
peroxide for 24 h as oxidative stress, as previously described
(Fukui et al., 2011). The day after the cells were transfected
(lipofectamine 2000, Invitrogen) with 5 nmol of miR-7b-3p
mimic (Invitrogen) and after 72 h collected for RNA and protein
extraction.
Cell RNA Extraction and qPCR
To perform qPCR to measure the expression level of miR-7b-
3p, cells were treated as follows: medium was removed and
cells were incubated with trypsin-EDTA 0.05% at 37◦C. Then
the detached cells were centrifuged at 1,000 RPM for 5 min,
washed with 1× PBS and pellet was stored at −80◦C. RNA was
extracted and quantified by Nanodrop as previously described
for in vivo experiments. RNA purification was applied before
performing the qPCR for miR-7b-3p using a solution of 1/10
volume of NH4OAC (0.5 M), 2.5 volume of cold 100% EtOH
and 1 µl of glycogen (Invitrogen) for each tube. Samples were
incubated at 80◦C for 30 min and centrifuged at 12,000 g at 4◦C
for 20 min. The supernatant was removed, the pellet washed with
75% cold EtOH and centrifuged again at 12,000 g at 4◦C for
5 min. The pellet was resuspended in DEPC water. RNA samples
were stored at−80◦C before qPCR. qPCR at 1, 7, and 18 days was
conducted in triplicate. The qPCR for miR-7b-3p was performed
as previously described for in vivo experiments. The expression
values (7 and 18 days) were normalised to 1 day.
Nucleofection
Cortical neurons were electroporated immediately after tissue
dissociation and before plating using the rat neuron nucleofector
kit (Amaxa, Switzerland). In brief, 500,000 cells were centrifuged
for 5 min at 1,000 rpm. After that, supernatant was removed and
neurons were resuspended in 100 µl of Nucleofector solution.
Then, 5 nmol of miR-7b-3p mimic (Invitrogen) per 1 × 106 cells
or negative control (Invitrogen) were added to the suspension
(Buller et al., 2010). Neurons were electroporated with the Amaxa
programme O-003. Finally, neurons were plated on poly-L-
lysinate coverslip at a final concentration of 32,500 cells/cm2.
Immunocytochemistry
Three days after nucleofection, cortical neurons grown on
coverslips were fixed with 4% PFA for 15 min and rinsed three
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times in 1× PBS. Permeabilisation was carried out with 0.1%
TritonX-100/1× PBS for 5 min and non-specific binding sites
were blocked by 5% BSA/PBS for 30 min. The following primary
antibodies were incubated for 1 h: 1:200 monoclonal mouse
anti-SMI-32 (Biolegend, SMI-32P San Diego, CA, United States),
1:1,000 monoclonal rabbit anti-βIII-tubulin III (Sigma-Aldrich,
T8660, St Luois, MO, United States) and 1:400 monoclonal
cleaved caspase 3 (9664, Cell Signaling). After washing in 1×
PBS, primary antibodies were detected with anti-rabbit or anti-
mouse cyanine 3-conjugated secondary antibodies, anti-rabbit
Alexa-596 conjugated secondary antibody and Phalloidin TRITC
(Sigma-Aldrich) 546 (1:1,000) for 30 min. Once mounted,
samples were examined and images acquired using an Olympus
Fluoview 300 confocal laser scanning microscope (CLSM).
To check miR-7b-3p overexpression, qPCR was performed in
triplicates on samples at 3 days after nucleofection.
In vitro Morphometric Analysis and
Evaluation of Apoptosis
The images acquired at CLSM were then analysed with ImageJ
software. Five different parameters were measured, (i) axon
length (n = 3), (ii) number of neurites (n = 3), (iii) area of the
growth cone (n = 5), (iv) percentage of the growth cone shape
(n = 5), and (v) stage of the neuronal development (n = 4).
Differentiated cells were defined as those bearing at least one
neurite longer than twice the cell body. For each experiment at
least 30 axons/neurites were measured. The same cells were also
analysed for the number of dendrites emerging from the cell
body. Both measures were expressed as the total mean length for
cell electroporated with negative control and miR-7b-3p mimic.
The area of the growth cones was measured by tracing in ImageJ
while the percentage of the growth cone shape was calculated as
the ratio of one growth cone morphology (fork, hand, and stick)
on the total number of growth cones. The classification of the
stage of neuronal development (stage I, II, and III) was analysed
as previously described (Takano et al., 2015). Here the percentage
of neurons at each stage was calculated on the total number of
neurons analysed.
As concerns, the analysis of apoptotic signs/markers, the
morphology of the nuclei and the expression of cleaved caspase 3
were analysed. A number >30 of neurons were analysed in sham
and mimic conditions and results presented as the percentage of
apoptotic nuclei or cleaved caspase 3-positive cells over the total
number of nuclei/cells.
Western Blotting
After 72 h from the transfection, both primary cortical neurons
and N2a were collected (n = 3), the lysate centrifuged and
the protein content measured by the BCA protein assay kit
(Invitrogen). Protein extracts (15 µg) were separated on 10%
SDS-poly-acrylamide gels and transferred to PVDF membranes.
After washing in Tris–HCl-buffered saline 0.2% Tween-20
(TBST), the membranes were blocked for 1 h at RT in TBST
with 5% milk and eventually incubated with the primary
antibody (1:2,000 α-actin, A2066; 0.4 µg/ml Wipf2-HPA024467,
Sigma-Aldrich) overnight at 4◦C. Goat anti-rabbit IgG HRP
(Invitrogen) was used as secondary antibody (1:2,000) for 1h
at RT. The protein bands were detected with a western light
chemiluminescence detection system (ECL, GE Healthcare Bio-
Sciences AB) and photographed in an ImageQuant LAS 4,000
mini (GE Healthcare Bio-Sciences AB). The images were analysed
by ImageJ, and cropped for presentation.
Statistical Analysis
Data were evaluated as mean ± standard error of mean (SEM).
Statistical analysis was performed using Prism 6.0 (GraphPad,
San Diego, CA, United States). For the histological analysis
the percentage of GFAP/IBA1 positive area was quantified
using ImageJ and analysed with a non-parametric t-test
(Mann–Whitney). Values p ≤ 0.05 were considered statistically
significant. In the sRNA library preparation and sequencing
experiments, the empirical differential expression analysis was
confirmed by parametric (t-tests) and non-parametric (Mann–
Whiney U) tests. For the statistical tests we considered p < 0.05
as statistically significant. miRNAs were considered differentially
expressed if there was a >0.5 log2 fold change between controls
and treatments, i.e., more than 1.5-fold change. To validate
miR-7b-3p and its targets by qPCR, changes in miRNA/gene
levels were detected as the difference in threshold cycle (1CT)
between the target gene and the housekeeping gene. The results
were analysed by Mann–Whitney test and t-test and presented
as normalised values between SHAM controls and SCI groups.
In the nucleofection experiments, the statistical analysis was
performed by a non-parametric t-test (Mann–Whitney). For the
morphometric analysis t-test was employed for the axon length,
number of neurites and growth cone analysis, the χ2 test was
employed for the neuron stage analysis and values p ≤ 0.05 were
considered statistically significant. The count of apoptotic nuclei
and the expression of cleaved caspase 3 was analysed by t-test. In
the western blotting the protein bands were analysed by t-test and
the data presented as relative protein level.
RESULTS
SCI Triggers Neuroinflammation but Not
Evident Neuronal Degeneration at
Cortical Level
C57BL/6J male mice underwent a complete spinal cord
transection at the cervical level 6 (C6) by a syringe needle. To
characterise this injury model, we analysed the inflammatory
reaction and the presence of degenerating cells in sensorimotor
cortex 12 h and 3 days post SCI in both young (P15) and adult
cohorts (P90). The level of microglia activation (IBA-1 positivity)
increased in all the SCI groups (t-test, t-statistic, p < 0.0001) also
at the cortical level (Supplementary Figure 1). In adult mice no
signs of astrogliosis (GFAP reactivity) were observed in the cortex
(data not shown). Altogether these results suggest that the spinal
cord lesion can trigger an inflammatory response also at cortical
level. We did not detect degenerating cells by FJC staining in the
sensorimotor cortex, whereas degenerating cells were markedly
visible in the spinal cord of SCI mice (Supplementary Figure 2).
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FIGURE 1 | Deregulated miRNA after SCI. Heat map based on log2 fold change values of 110 DE miRNAs in at least one of the comparisons between cohorts (P15
12 h, P15 3 days, P90 12 h, P90 3 days) plus corresponding controls. The z-score represents the deviation from the mean by standard deviation units; n = 3 for
each experimental group.
These results seem to indicate that the lesion model does not
activate a cell death pathway at the cortical level.
miR-7b-3p Is the Major Upregulated
miRNA in SCI-Sequencing Profile
To evaluate miRNA differential expression after SCI, a complete
transection of the spinal cord was performed in P-15 and P-90
mice. sRNA sequencing was then performed on isolated layer
V sensorimotor cortex tissue, sampled at 12 h and 3 days after
SCI (Figure 1).
To select a candidate miRNA for further investigation,
we looked for correlations/relationships between differentially
expressed (DE) miRNAs and groups. Three miRNAs were
upregulated (miR-551b-5p, miR-6481, and miR-5126), while four
were downregulated (miR-1298-5p, miR-668-3p, miR-671-5p,
and miR-709) and shared between two groups. Instead miR-7b-
3p and miR-26a-1-3p were both upregulated and shared among
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• Chen et al., 2010
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• Zhao et al., 2012
• McMillan et al., 2017
• Beveridge and Cairns,
2012
• Liu et al., 2009
• Liu et al., 2018
No validated targets
miRNA functional analysis by miRpub, PubMed, and miRWalk. In the second column, log2 fold change is reported (n = 3).
FIGURE 2 | miR-7b-3p upregulation following SCI. miR-7b-3p upregulation in all SCI groups was confirmed by RT-PCR. The graph expresses miRNA normalised
relative expression values ± SEM (Mann–Whitney ***p < 0.001; **p < 0.01; n = 8 for each group).
three groups (P15-12 h, P90-12 h, and P90-3days, and P15-12 h,
P15-3 days, and P90-12 h, respectively). These two miRNAs were
found in both young and adult mice with miR-7b-3p showing the
highest fold change (log2 fold change) when compared to controls
(Table 1). This data suggested that miR-7b-3p could perform
gene regulatory functions related to SCI independent of animal
age and may have stronger biological/clinical relevance. To better
understand the role of miR-7b-3p, we screened the literature
using PubMed and miRpub, a specific database collating miRNA-
related articles. We focused on functions related to neurite/axon
outgrowth during development, following a lesion and/or
specifically related to SCI. Although some evidence had been
reported in the literature for miR-7b-3p, there were no validated
target genes reported in miRWalk (Table 1).
q-PCR Confirmed the Upregulation of
miR-7b-3p in the Cortex of SCI
To confirm the sequencing results, miR-7b-3p was further
analysed by qPCR to confirm its DE in SCI compared to SHAM
controls. A significant upregulated fold change of 2.28 ± 0.37,
1.57 ± 0.85, and 9.8 ± 3.01 times was observed for miR-7b-
3p in SCI P-15 12 h, P-90 12 h, and P-90 3 days, respectively,
compared to controls (t-test, t-statistic, SHAM vs SCI p < 0.0006
in P-15 12 h; p < 0.007 in P-90 12 h; p < 0.007 in P-90 3 days).
We also found that miR-7b-3p expression level was 6.16 ± 2.02
times higher in SCI P-15 3 days mice compared to SHAM
controls (Figure 2; t-test, t-statistic, SHAM vs SCI p < 0.004). The
expression of miR-7b-3p increased over time between 12 h and
3 days in both animal age groups. This data suggested that miR-
7b-3p could exert a specific role connected to SCI independently
of animal age and time after lesion induction.
miR-7b-3p Targets Genes Essential for
Neurite Outgrowth
To better investigate the role of miR-7b-3p in regulating the axon
guidance process, we validated several miR-7b-3p target genes
by qPCR. Since the seed sequence is shared between miR-7a-
2-3p and miR-7b-3p, we first analysed the seven genes already
Frontiers in Molecular Biosciences | www.frontiersin.org 7 March 2021 | Volume 8 | Article 618869
fmolb-08-618869 March 25, 2021 Time: 18:33 # 8
Ghibaudi et al. miR-7b-3p in Spinal Cord Injury
FIGURE 3 | The targets of miR-7b-3p. (A) Two/seven genes were found to be up and downregulated in P15-3d SCI group, while three/four resulted upregulated in
P-90-3 days SCI (B). The graphs express normalised relative expression values (RT-PCR) ± SEM (t-test **p ≤ 0.002; *p < 0.01; n = 5 for each group).
known to be targets of the first miRNA and directly linked
to different neuronal processes (Supplementary Table 1). As
shown in Figure 3, Wipf2 expression (t-test, t-statistic, p = 0.02)
decreased in SCI P-15 3 days animals compared to controls
(Figure 3A); Zdhhc9 expression (t-test, t-statistic, p = 0.002)
was increased in SCI P-15 3 days (Figure 3A); Prkcb (t-test,
t-statistic, p = 0.04), Wipf2 (t-test, t-statistic, p = 0.02), and
Pfn2 (t-test, t-statistic, p = 0.01) were increased in P-90 3 days
SCI mice compared to SHAM controls (SMAH vs SCI). Since
Wipf2 is known to be essential for neurite outgrowth/extension,
this result implicates its possibility as a direct miR-7b-3p target.
Considering that Zdhhc9, Prkcb, and Pfn2 are linked to axon
growth (Supplementary Table 1), their upregulation in SCI
could represent an indirect link between miR-7b-3p and their
relative expression.
We then screened a selected list of genes predicted to be
targets of miR-7b-3p by qPCR custom plates in two of the
experimental groups. We chose 66 genes belonging to the
following KEGG pathways: axon guidance, negative regulation
of anoikis, regulation of actin cytoskeleton, PI3K-Akt signalling
pathway. Among all the genes analysed, 16 were downregulated
in the cortex of SCI mice and among them, two (G6pc and Ntrk2)
were shared between the two groups (Figure 4). Only some
genes have been experimentally demonstrated as key components
of the KEGG pathways. The function of some genes such as
G6pc, Ptrh2, and Itgb3 in this context remains unclear (see
Supplementary Table 2).
miR-7b-3p Is Not Responsible of Neurite
Outgrowth During in vitro Cortical
Neuron Development
In order to better understand the role of miR-7b-3p, we
evaluated whether this miRNA could be related to the axon
growth during cortical neuron development, a function
that could be exploited as potential SCI target (Hilton and
Bradke, 2017). We used an in vitro system to mimic three
different time points, 1, 7, and 18 days corresponding to
the undifferentiated neuron stage, dendritogenesis beginning
stage, and mature neuron stage, respectively (Figure 5A).
miR-7b-3p expression was constant during neuron development
with slight oscillations among the time groups possibly
suggesting its expression change reactivation only after
SCI (Figure 5A).
To further analyse miR-7b-3p function during development,
we studied in vitro the morphological phenotype of cortical
neurons in which we overexpressed this miRNA. Cells transfected
with miR-7b-3p mimic showed a significant upregulation of
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FIGURE 4 | Custom card of putative miR-7b-3p targets. Downregulated genes in P-90-12 h and P-15-3 days experimental groups. Data are shown as normalised
relative expression values of technical replicates (RT-PCR, n = 3 technical replicates; *p ≤ 0.04, **p ≤ 0.09, ***p ≤ 0.0006).
FIGURE 5 | miR-7b-3p expression and functional analysis in primary cortical neurons. (A) Developing in vitro cortical neurons, DIV-1 undifferentiated neuron stage,
DIV-7 dendritogenesis stage, and DIV-18 mature neuron stage; (B) miR-7b-3p expression at DIV-1-7-18 presented as normalised relative expression value
compared to DIV-1; (C) enriched annotation terms with a significant p-value analysed by miRWalk and DAVID 6.7 (n = 3; values expressed as –log10 p-value).
3.05 (t-test, t-statistic, p 0.02) times compared to the negative
control transfected cells (Figure 6A). However, miR-7b-3p
overexpression did not change the axon length or the number
of neurites (Figures 6A,B). These results suggest that miR-
7b-3p is not involved in neurite or axon growth during the
cortical development.
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FIGURE 6 | miR-7b-3p overexpression and its role in neurite outgrowth. (A) miR-7b-3p overexpression and measurement of axon length (n = 3) and number of
dendrites (n = 3). (B) Comparable axon length and number of dendrites in NC (negative control) and mimic-7b-3p electroporated cells. Scale bars: (B), 20 µm. The
graphs express miRNA normalised relative expression value, µm for axon length and number for neurites ± SEM (t-test *p 0.02).
miR-7b-3p Maintains the Cells in a More
Plastic Stage
Since no validated targets are known for this miRNA, we
performed a functional analysis based on putative targets
predicted by (i) miRWalk algorithm or (ii) miRWalk intersection
among 12 different databases. We considered only those
genes predicted by at least 6 databases for DAVID 6.7.
Different KEGG and GOBP neuronal related functions (mainly
connected to axon cytoskeleton, neural development, and
apoptosis) showed a significant p-value (Bonferroni post hoc test,
p ≤ 0.03, Figure 5C). Only two KEGG neuronal functions (axon
guidance and regulation of actin cytoskeleton) reached statistical
significance (Figure 5C).
On the basis of these results, we explored the effect of miR-7b-
3p overexpression on the growth cone area and shape of cortical
neurons. However, the total growth cone area was not affected
by the transfection of miR-7b-3p mimic (Figure 7A). Similarly,
the analysis of the ratio of the growth cone shape (forked, stick,
and hand) on the total number of growth cone (expressed in
percentage) did not reveal any significant change overexpressing
the miRNA (Figures 7A,B).
During development cortical neurons switch from a round
shape (stage I) to a ramified middle stage (stage II) and eventually
reach the stage III in which the longest branch will become
the axon of the neuron (Figure 8). We analysed the percentage
of cells at each stage after mimic transfection. Interestingly,
miR-7b-3p overexpression significantly increased the percentage
of neurons at stage II (χ2 test, p = 0.04) (Figure 8). These results
suggest a role of miR-7b-3p in maintaining the cells in a more
immature and, likely plastic, neuronal developmental phase.
miR-7b-3p Reduces Apoptosis in
Primary Cortical Neurons
The functional analysis based on putative targets of miR-7b-3p
also included the class of genes related to apoptosis. We then
explored the effect of the overexpression of the miR-7b-3p in
cortical neurons, evaluating the morphology of the nuclei and the
expression of cleaved caspase 3 (a well know apoptotic marker;
Crowley and Waterhouse, 2016). The overexpression of miR-
7b-3p resulted in a significant lower percentage of apoptotic
nuclei (Figure 9, t-test, t-statistic, p = 0.03) and a reduced
expression of cleaved caspase 3 compared to the control cells.
This result indicates that miR-7b-3p can counteract the apoptotic
mechanisms and exert a neuroprotective effect.
In vitro miR-7b-3p Overexpression
Reduces Wipf2 Expression in Damaged
but Not in Healthy Neurons
We finally investigated the effect of miR-7b-3p overexpression
on Wipf2 expression, one of the predicted target genes whose
transcript was downregulated in P-15-3d mice (Figure 3). In
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FIGURE 7 | Growth cone analysis in cortical neurons overexpressing miR-7b-3p. (A) Measurement of the growth cone area and the percentage of “hand,” “forked,”
and “stick” growth cone shape in mimic transfected cells. (B) “hand,” “forked,” and “stick” growth cone shape analysed in cortical neurons with SMI-32
(neurofilament in white), βIII-tubulin (cytoskeleton in green), phalloidin (actin in red). Scale bar: 20 µm. The graphs express the area and the percentage of each type
of growth cone/total growth cone number ± SEM (n = 5; t-test n.s.).
healthy primary cortical neurons, the miRNA overexpression
does not affect the Wipf2 protein expression, as shown in
Figure 10A. However, N2a cells overexpressing miR-7b-3p
(Supplementary Figure 3) upon an oxidative stress (H2O2
administration, mimicking the SCI environment), exhibited a
significant decreased expression of Wipf2 (Figure 10B). This
result confirms Wipf2 as a direct target of miR-7b-3p, but only
in damage conditions. Therefore, miR-7b-3p can downregulate
the expression of neurite growth/regeneration related genes (as
Wipf2) and, once again, this supports the hypothesis that miR-
7b-3p can maintain the cells in a more immature state, possibly
at the expense of the axon growth.
DISCUSSION
We investigated the miRNA profile in SCI in order to
identify specific miRNAs involved in regeneration/plasticity.
We performed next generation sequencing of the layer V
sensorimotor cortex in both young and adult mice to evaluate
miRNA dysregulation 12 h and 3 days after SCI. The only miRNA
significantly upregulated in all of the evaluated conditions
was miR-7b-3p, whose function in spinal cord lesion was the
focus of this work.
Several studies analysed the global profiling of miRNA
expression after SCI obtaining differential expression for a
great number of sRNAs (Liu et al., 2009). Some miRNAs
acting on different pathways promote functional recovery. For
instance, miR-133b is an important determinant for axon
regrowth and functional recovery by reducing RhoA protein in
an adult zebrafish SCI model (Yu et al., 2011). miR-124 has
been demonstrated to control at least four different pathways
(PI3K/AKT, REST, and Rho1) all related to axon regrowth after
injury (Ghibaudi et al., 2017). Despite the growing number of
miRNAs connected to SCI condition, we still lack a complete
comprehension of this phenomenon.
To identify a wider collection of miRNAs
overexpressed/downregulated following SCI, we performed
sRNA library construction with a recently improved technique
(Sorefan et al., 2012; Xu et al., 2015). This method employs HD
adapters that contain degenerate nucleotides at their ligating
ends, allowing for the formation of more stable secondary
structures between miRNAs and adapters prior to sequencing.
Using this approach, sequencing bias in biological samples
can be reduced and the representation of low abundance
miRNAs increases leading to the identification of previously
unknown miRNAs. For all the groups tested, sequencing
generated a list of miRNAs potentially dysregulated in SCI
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FIGURE 8 | moiR-7b-3p increases the number of neurons in stage II. The number of stage I, II, and III neurons is expressed as a percentage on the total number of
neurons analysed. An increased stage II number of neurons is shown (n = 4; t-test *p ≤ 0.05 for stage II).
cortex compared to SHAM control groups. Some miRNAs
such as miR-7b-3p were reported more than once in the
same group (Table 1). This repetition is due to the fact
that slightly different sequences have been attributed to the
same miRNA name. We chose the sequence with the most
abundant number of reads as the most valid, such as in the
case of miR-7b-3p.
MicroRNAs act in a network system in which different
members can converge on the same transcripts (targets), on
the same pathways or on the same functions (Barca-Mayo
and De Pietri Tonelli, 2014; Ghibaudi et al., 2017). miRNet
analysis did not reveal any significant interaction among the
dysregulated miRNAs within each group or shared among
the groups analysed (P-15 12 h and 3 days; P-90 12 h and
3 days). A list of seven miRNAs emerged as potentially related
to axon growth, plasticity and regeneration pathways possibly
reactivated after SCI. Consistent with this hypothesis, among
the miRNAs predicted to be up/downregulated, only miR-7b-
3p upregulation was confirmed by qPCR in three SCI groups
(P-15 12 h and P-90 12 h, 3 days). miR-7b-3p belongs to
the evolutionary conserved miR-7 family implicated in the
normal function of different organs (pancreas, heart, and
skin) with a particular enrichment profile in brain (Horsham
et al., 2015). Indeed, specific RNA binding proteins and
transcription factors (hnRNP and Yan) ensure miR-7 expression
in neuronal cells and a refined control of cell differentiation
through a negative feedback loop mechanism (Arora et al.,
2013; Choudhury et al., 2013). Consistently with the functional
analysis of the putative predicted targets of miR-7b-3p, we
focused on three gene classes: axon cytoskeleton, neural
development, and apoptosis.
The role of the miR-7 family in the CNS is heterogeneous
ranging from neuroprotective effect to alleviation of the
inflammatory reaction in Parkinson’s disease (PD) and stroke,
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FIGURE 9 | miR-7b-3p reduces the number of apoptotic neurons in vitro. (A) Analysis of the percentage of apoptotic nuclei (% values ± SEM, t-test, *p = 0.03) and
cleaved caspase 3 in mimic overexpressing cells. (B) Cleaved caspase 3 expression (red), SMI-32 (green), DAPI (blue) in CTRL and MIMIC cortical neurons.
respectively (McMillan et al., 2017; Zhang et al., 2018; Xu H. et al.,
2019). In SCI miR-7 function is poorly understood. The literature
often refers to other members of the miR-7 family that do not
share the same seed region with the miR-7b-3p here analysed. We
screened the validated targets involved in neuronal processes of
miR-7a-2-3p that has the same seed region of miR-7b-3p. Only
four genes were significantly modulated in SCI conditions. The
first gene, Wipf2, is a gene required for neurite branching and
outgrowth, lamellipodia formation and migration (Banzai et al.,
2000; Suetsugu et al., 2001; Kitamura et al., 2003; Kakimoto et al.,
2004; Takenawa, 2005; Xiao et al., 2008) whose level of expression
decreased in the P-15 3 days upon miR-7b-3p upregulation after
SCI. This result suggests Wipf2 as a direct target of the miR-
7b-3p, that unexpectedly seems to negatively influencing the
axonal regrowth after SCI. This was further demonstrated by our
in vitro experiments (Figure 10B). On the other hand, Zdhhc9,
Prkcb, and Pfn2 were found upregulated in P-15 3 days and
P-90 3 days groups. Among their different functions, all these
genes are required in the regulation of actin stability (Da Silva
et al., 2003), axon branching (Han et al., 2015; Holland and
Thomas, 2017) and neural maturation and differentiation (Guo
et al., 2012; Kaur et al., 2014), but their role after injury has
not been postulated. Consistently with their known functions
and the increased level of expression we found after SCI, their
reactivation can be interpreted as an indirect effect of miR-7b-3p
overexpression. This could therefore indicate the presence of
secondary elements controlled by miR-7b-3p that lead to the
reactivation of specific neuronal pathways.
We extended the analysis to those genes predicted by
miRWalk as direct targets of miR-7b-3p, finding that 16 genes
were downregulated in the SCI cortex of P-15 3 days and P-90
12 h. Only 2 of these 16 genes were the genes shared between
the young and adult group, G6pc and Ntrk2. While G6pc role still
remain unclear in this specific context (Supplementary Table 2),
Ntrk2 is known to control neurogenesis and axonal sprouting.
miR-7b-3p overexpression decreases the level of 14 other genes
in the P-15 3 days group (Supplementary Table 2). These
genes are all involved in developmental axon guidance, neurite
outgrowth and neurogenesis processes at different extents. The
fact that some of them, including Arhgef12, Ephb1, and Pak6,
have been already described to be upregulated in SCI can be
ascribed to the different injury models employed and to the
tissue in which the analysis has been conducted. Most of the
SCI experiments are focused on the spinal injured tissue, while
we shifted the observation at the cortical level so introducing a
different perspective and revealing new potential targets.
Since it is known that the injured adult CNS re-expresses
genes and activates pathways that are observed during neuronal
development (Emery et al., 2003), we explored the function
of this miRNA while this process is occurring. The expression
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FIGURE 10 | miR-7b-3p overexpression in vitro reduces Wipf2 protein level upon oxidative stress condition. (A) After miR-7b-3p mimic transfection, the relative
expression of Wipf2 protein was quantified both in primary cortical neurons in healthy state and (B) in N2a cells undergone oxidative stress condition. Data are
shown as normalized relative expression values (n = 3, **p ≤ 0.001).
of miR-7b-3p was constant during the in vitro neuronal
developmental steps (Figure 5), as well as its overexpression
in primary cortical neurons did not affect neither axon length
nor the number of neurites nor the growth cone area or
the percentage of different type of growth cones (Figures 6,
7). Conversely, the analysis of the neuronal stages showed
that miR-7b-3p mimic increased the percentage of cells at
stage II, a ramified middle stage (Figure 8), representing an
intermediate phase of neuronal development where the cell must
still determine which neurite will become the axon. This result
suggests that, eventually also in case of SCI, increased level
of miR-7b-3p could make the damaged neurons more plastic,
in an attempt of the cell in refining the growth of neurites.
This mechanism is part of the sprouting process required for
a proper regeneration after a lesion and known to partially
involve the reactivation of specific developmental pathways
(Hilton and Bradke, 2017).
Altogether, these results can be actually explained by a
complex and subtle role of miR-7b-3p. Indeed, the regrowth
of a severed axon is a spatially and temporally controlled
mechanism that needs to be timely regulated in order to find the
most appropriate environmental conditions (Fawcett, 2020). In
this context, it is possible that miR-7b-3p downregulates genes
promoting axon regeneration, maintaining the neurons in a more
plastic phase (resembling the in vitro stage II) redefining the
neurite will be the axon.
The conservation of genes involved in the
regeneration/plasticity process could also be the key to explain
the absence of differences we observed between the young and
the adult SCI groups. Although at P-90 the nervous system
is considered completely mature and less plastic compared to
P-15 (when neuronal networks are still defining), the molecular
pathways promoting the functional recovery after SCI involve
neuronal development pathways (such as Wnt pathway) that are
highly evolutionary conserved (Herman et al., 2018; Squair et al.,
2018).
Moreover, interestingly, our data suggest another role of miR-
7b-3p, linked to neuroprotection. It has been demonstrated
that miR-7 silences pro-apoptotic genes (Pollock et al., 2014),
a functional class that we also observed to be enriched in
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miR-7b-3p functional analysis (Figure 5C), and protects motor
neuron in vitro (Chakrabarti et al., 2014). It has been recently
shown that miR-7 (member of the same family) exerts a
neuroprotective effect in PD directly acting on α-synuclein and
reducing the apoptotic mechanism (Je and Kim, 2017; Tarale
et al., 2018; Salama et al., 2020). These data are in line with
our results showing that miR-7b-3p overexpression reduces the
percentage of apoptotic nuclei and the expression level of cleaved
caspase 3 (Figure 9).
Overall, we can hypothesize an intriguing dual role of
miR-7b-3p in: (i) the induction of a more plastic neuronal
condition/phase, possibly at the expense of the axon regeneration
(as also demonstrated by our in vitro experiments), (ii) the
neuroprotective role exerted through the inhibition of the
apoptotic cascade. Overall, our findings suggest that increasing
the miR-7b-3p levels in case of SCI could reactivate in adult
neurons silenced developmental programmes, supporting at the
same time the survival of the axotomised neurons.
Lastly, a final consideration on our results is needed to
explain the few differences we observed in our experiments:
(i) the miRNA sequencing profile we analysed derived from a
mixed cell population also containing astrocytes, microglia and
interneurons whose contribution cannot be totally excluded; (ii)
the primary cortical neuron model we employed does not fully
recapitulate the pathophysiological phases occurring after SCI,
thus probably underestimating some possible additional effects.
CONCLUSION
MicroRNAs emerged as new alternative targets in SCI as they
are a potent inner regulatory system of gene expression that
can be manipulated. We laid the groundwork for the future
investigation of the potential roles of miR-7b-3p, whose action
can represent an intriguing therapeutic target. Although these
experiments need further confirmation, miR-7b-3p could be
linked to the modulation of plasticity-related genes and to a
neuroprotective function, both part of the same mechanism to
support the survival and regeneration after SCI. Manipulation
of one single miRNA cannot be considered the most effective
therapeutic strategy, but our results allowed to better understand
miRNA mechanisms of action and add new elements to the
miRNA complex network in SCI. A more complete list of long
non-coding RNA involved in the regrowth programme will help
to design integrative approaches with a stable and successful
therapeutic value.
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